What is C-reactive protein telling us about coronary artery disease?

Archives of Internal Medicine

Volumn 162, Issue 4, 2002, Pages 389-392

  Levinson, Stanley S ^a   Elin, Ronald J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN; TROPONIN;

AGE; BODY WEIGHT; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DISEASE COURSE; HEART INFARCTION; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; NOTE; PLASMA; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELIABILITY; REPRODUCIBILITY; RISK ASSESSMENT; SEX DIFFERENCE; SEX RATIO;

EID: 0037169923     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.4.389     Document Type: Note

References (28)

1. Serological reactions in pneumonia with a non protein somatic fraction of pneumococcus
2. C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes
3. Molecular genetics, structure and function of C-reactive protein
4. Atherosclerosis - An inflammatory disease
5. Novel inflammatory markers of coronary risk: Theory versus practice
6. Inflammation in cardiovascular disease: Cart, horse, or both
7. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease
8. Guidelines on selection of laboratory tests for monitoring the acute phase response
9. Prospective study of C-reactive protein and risk of future cardiovascular events among apparently healthy women
10. Evaluation of four automated high-sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications
11. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
12. Hormone replacement therapy and increased plasma concentration of C-reactive protein
13. The azithromycin in coronary artery disease: Elimination of myocardial infection with chlamydia (ACADEMIC) study
14. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992
15. Elevated C-reactive protein levels in overweight and obese adults
16. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women
17. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening
18. C-reactive proteins and other markers of inflammation in prediction of cardiovascular disease in women
19. Relationships between triglycerldes, lipoproteins, glucose and coronary artery disease
20. C-reactive protein in the prediction of cardiovascular disease
21. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study
22. Prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
23. Prognostic influences of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease
24. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease
25. Acute phase proteins and other systemic responses to inflammation
26. Complement and atherogenesis: Binding of CRP to degraded, nonoxidized LDL enhances complement activation
27. American thyroid assessment of current free thyroid hormone and thyrotropin measurements and guidelines for future clinical assays